2018 International Congress Archives - Page 55 of 177

1:45pm-3:15pm: The impact of thalamic lesions on visuomotor behavior: A behavioral and fMRI study

M. Wilke, C. Schmidt-Samoa, P. Dechent, K. Miloserdov, J. Liman, M. Holzgraefe, I. Kagan, M. Bähr (Goettingen, Germany)

Neuroimaging (Non-PD) · Hall 3FG

1:45pm-3:15pm: The Impact of Vocal Fold Augmentation with Injection Laryngoplasty on Voice Quality in Patients with Parkinson Disease

O. Klepitskaya, J. Barr, Y. Liu, S. Sillau, J. Litts, D. Fink, M. Shaffer, J. Newcombe, A. Klepitskaya, M. Clary (Aurora, CO, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: The Interface of advanced therapies as Parkinson’s disease progresses – case reports

C. Liang, S. Williams, L. Jones, C. Sue, P. Silberstein (St Leonards, Australia)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: The NIC-PD-study –A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson‘s disease in Germany and N. America

W. Oertel, H. Müller, C. Schade-Brittinger, C. Kamp, K. Balthasar, K. Articus, M. Brinkman, C. Venuto, M. Unger, K. Eggert, D. Vadasz, K. Kieburtz, J. Boyd (Marburg, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: The nigral hyperintensity on 3 Tesla susceptibility-weighted MRI in patients with vascular parkinsonism

K.J. Kim, Y.J. Bae, J.M. Kim, S.E. Kim, B.S. Jeon (Goyang, Republic of Korea)

Neuroimaging (Non-PD) · Hall 3FG

1:45pm-3:15pm: The outcome of directional subthalamic deep brain stimulation in advanced Parkinson’s disease

M. Koivu, F. Scheperjans, J. Eerola-Rautio, J. Resendiz-Nieves, J. Marjamaa, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: The PDSAFE falls prevention programe for people with Parkinson’s: A multicentre randomised controlled trial

A. Ashburn, R. Pickering, L. Rochester, H. Roberts, C. Ballinger, S. Hulbert, I. Marian, C. Fitton, E. McIntosh, V. Goodwin, A. Nieuwboer, S. Lamb, K. Chivers Seymour (Southampton, United Kingdom)

Clinical Trials and Therapy in Movement Disorders · Hall 3FG

1:45pm-3:15pm: The possibility of medicamentous correction of the lower urinary tract dysfunction in patients with Parkinson’s disease

M. Tukhtamishev, T. Khodjimetov, F. Akhmedova (Tashkent, Uzbekistan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: The possible neuroprotective potential of galantamine along with soya-lecithin and hydroxychloroquine against ICV-STZ induced cognitive dysfunction in rats

A. Singh, A. Kumar (Patiala, India)

Cognitive Disorders · Hall 3FG

1:45pm-3:15pm: The relationship between family care giver number and progression speed of dementia

Y. Liu, S.L. Yang, Y.C. Wu (Shanghai, China)

Cognitive Disorders · Hall 3FG